Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Disipal

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
  • G. Zetler, E. Moog
  • Naunyn-Schmiedebergs Archiv für experimentelle…
  • 2004
  • Corpus ID: 34572960
ZusammenfassungDie „Katatonie“ erzeugende Wirkung von Bulbocapnin auf die Maus wurde quantitativ untersucht.Von 38 Substanzen… Expand
1999
1999
Abstract Orphenadrine is an anticholinergic drug used mainly in the treatment of Parkinson's disease. It has a peripheral and… Expand
1980
1980
  • N. Fraser
  • British medical journal
  • 1980
  • Corpus ID: 41247255
In the 20 years 1958-77 598 deaths were registered as due to accidental poisoning in British children under the age of 10-343… Expand
1978
1978
1977
1977
Studies were undertaken to elucidate whether orphenadrine influences thyroid function. Seven volunteers were given orphenadrine… Expand
1974
1974
. Three clinically euthyroid patients with parkinsonism were found to have raised levels of protein-bound thyroxine (T4(D)). It… Expand
1965
1965
  • R. Strang
  • Journal of the American Geriatrics Society
  • 1965
  • Corpus ID: 27196484
The following investigation was undertaken to evaluate “preferentially” the use of trihexyphenidyl (Artane) and orphenadrine… Expand
1963
1963
The psychomotor behaviour of 10 patients showing good therapeutic response to Haloperidol was studied. An attempt was made to… Expand
  • figure 1
1959
1959
A cure for "shaking palsy" appears as remote today as one hundred and fifty years ago when Sir James Parkinson first described… Expand
1957
1957
• Orphenadrine in doses generally of 50 mg. thrice daily was given to 176 patients with paralysis agitans. It was found to be… Expand